Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 150

1.

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.

Zhu MX, Wei CY, Zhang PF, Gao DM, Chen J, Zhao Y, Dong SS, Liu BB.

J Exp Clin Cancer Res. 2019 Sep 18;38(1):409. doi: 10.1186/s13046-019-1401-y.

2.

LINC00957 Acted as Prognostic Marker Was Associated With Fluorouracil Resistance in Human Colorectal Cancer.

Zhang LH, Li LH, Zhang PF, Cai YF, Hua D.

Front Oncol. 2019 Aug 21;9:776. doi: 10.3389/fonc.2019.00776. eCollection 2019.

3.

Ortho-phenylphenol exposure impairs porcine sperm motility through AMPK/AKT signaling pathway.

Yang LL, Zhang PF, Zhang TY, Shen W, Zhao Y, Yin S.

Environ Mol Mutagen. 2019 Aug 27. doi: 10.1002/em.22324. [Epub ahead of print]

PMID:
31454112
4.

Elevated kindlin-2 promotes tumour progression and angiogenesis through the mTOR/VEGFA pathway in melanoma.

Wei CY, Zhu MX, Zhang PF, Yang X, Wang L, Ying JH, Luan WJ, Chen C, Liu JQ, Zhu M, Yang YW, Feng ZH, Qi FZ, Gu JY.

Aging (Albany NY). 2019 Aug 19;11(16):6273-6285. doi: 10.18632/aging.102187. Epub 2019 Aug 19.

5.
6.

Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors.

Lu JC, Zeng HY, Sun QM, Meng QN, Huang XY, Zhang PF, Yang X, Peng R, Gao C, Wei CY, Shen YH, Cai JB, Dong RZ, Shi YH, Sun HC, Shi YG, Zhou J, Fan J, Ke AW, Yang LX, Shi GM.

Theranostics. 2019 Jul 9;9(16):4678-4687. doi: 10.7150/thno.36276. eCollection 2019.

7.

Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.

Zhang PF, Wei CY, Huang XY, Peng R, Yang X, Lu JC, Zhang C, Gao C, Cai JB, Gao PT, Gao DM, Shi GM, Ke AW, Fan J.

Mol Cancer. 2019 Jun 1;18(1):105. doi: 10.1186/s12943-019-1031-1.

8.

[Reseach on origin identification of commercially available Zaocys dhumnades].

Jin JK, Yang QS, Chen MX, Yao Q, Ding ZF, Zhang PF, Wang J, Yang K.

Zhongguo Zhong Yao Za Zhi. 2019 Apr;44(7):1321-1326. doi: 10.19540/j.cnki.cjcmm.20190129.009. Chinese.

PMID:
31090287
9.

Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2.

Bi W, Xiao JC, Liu RJ, Zhou LY, Zhang S, Yang M, Zhang PF.

Invest New Drugs. 2019 May 11. doi: 10.1007/s10637-019-00792-6. [Epub ahead of print]

PMID:
31076964
10.

Paired eye-control study of unilateral opaque bubble layer in femtosecond laser assisted laser in situ keratomileusis.

Wei CH, Dai QY, Mei LX, Ge Y, Zhang PF, Song E.

Int J Ophthalmol. 2019 Apr 18;12(4):654-659. doi: 10.18240/ijo.2019.04.21. eCollection 2019.

11.

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.

Peng R, Zhang PF, Yang X, Wei CY, Huang XY, Cai JB, Lu JC, Gao C, Sun HX, Gao Q, Bai DS, Shi GM, Ke AW, Fan J.

J Exp Clin Cancer Res. 2019 Mar 5;38(1):113. doi: 10.1186/s13046-019-1113-3.

12.

Downregulation of RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma.

Wei CY, Zhu MX, Yang YW, Zhang PF, Yang X, Peng R, Gao C, Lu JC, Wang L, Deng XY, Lu NH, Qi FZ, Gu JY.

J Hematol Oncol. 2019 Mar 4;12(1):21. doi: 10.1186/s13045-019-0711-z.

13.

Influences of pressure on structural and electronic properties of four types of HMX.

Qin H, Shi MF, Feng ZJ, Zhang PF, Guo X, Chen XY, Liu FS, Tang B, Liu QJ.

J Mol Model. 2019 Feb 13;25(3):63. doi: 10.1007/s00894-019-3947-1.

PMID:
30756186
14.

Nucleolin promotes Ang II‑induced phenotypic transformation of vascular smooth muscle cells via interaction with tropoelastin mRNA.

Fang L, Zhang PF, Wang KK, Xiao ZL, Yang M, Yu ZX.

Int J Mol Med. 2019 Apr;43(4):1597-1610. doi: 10.3892/ijmm.2019.4090. Epub 2019 Feb 4.

15.

Discrete Hashing with Multiple Supervision.

Luo X, Zhang PF, Huang Z, Nie L, Xu XS.

IEEE Trans Image Process. 2019 Jan 11. doi: 10.1109/TIP.2019.2892703. [Epub ahead of print]

PMID:
30640611
16.

CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling.

Qiu BQ, Zhang PF, Xiong D, Xu JJ, Long X, Zhu SQ, Ye XD, Wu Y, Pei X, Zhang XM, Wu YB.

J Cell Physiol. 2019 Jul;234(7):11256-11264. doi: 10.1002/jcp.27783. Epub 2018 Nov 22.

PMID:
30565694
17.

The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p.

Yang X, Cai JB, Peng R, Wei CY, Lu JC, Gao C, Shen ZZ, Zhang PF, Huang XY, Ke AW, Shi GM, Fan J.

J Cell Physiol. 2019 Jul;234(7):12051-12060. doi: 10.1002/jcp.27869. Epub 2018 Dec 10.

18.

The lncRNA SCARNA2 mediates colorectal cancer chemoresistance through a conserved microRNA-342-3p target sequence.

Zhang PF, Wu J, Wu Y, Huang W, Liu M, Dong ZR, Xu BY, Jin Y, Wang F, Zhang XM.

J Cell Physiol. 2019 Jul;234(7):10157-10165. doi: 10.1002/jcp.27684. Epub 2018 Nov 15.

PMID:
30443961
19.

Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma.

Liu GM, Li Q, Zhang PF, Shen SL, Xie WX, Chen B, Wu J, Hu WJ, Huang XY, Peng BG.

Cell Death Dis. 2018 Nov 14;9(11):1132. doi: 10.1038/s41419-018-1165-x.

20.

Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.

Wei CY, Zhu MX, Lu NH, Peng R, Yang X, Zhang PF, Wang L, Gu JY.

Oncogene. 2019 Mar;38(11):1876-1891. doi: 10.1038/s41388-018-0531-6. Epub 2018 Nov 1.

Supplemental Content

Loading ...
Support Center